Tokai University, School of Medicine, Isehara, Japan.
Japan Council for Quality Health Care, Tokyo, Japan.
J Gastroenterol. 2017 Sep;52(9):1013-1022. doi: 10.1007/s00535-017-1359-5. Epub 2017 Jun 26.
Endoscopic retrograde cholangiopancreatography (ERPC) is used for the diagnosis and treatment of pancreatic and biliary diseases. Post-ERCP pancreatitis (PEP) is a complication which needs special care and clinical practice guideline for this morbidity is also needed.
The key clinical issues of diagnosis and treatment of PEP were listed and checked, and then the clinical questions were formulated. PubMed (MEDLINE) and Ichushi-web (Japanese medical literature) were used as databases. For the study of diagnostic test accuracy, items similar to QUADAS-2, i.e., random selection from a population to which the diagnostic test is applied, blinding of index tests and reference tests, completeness of reference standard, completeness of test implementations, the same timing of tests, and missing data were assessed as well as the indirectness of the study subjects, index tests, reference standard, and outcomes. Grading of recommendations was determined as strong or weak. In clinical practice, the judgment of attending doctors should be more important than recommendations described in clinical practice guidelines. Gastroenterologists are the target users of this clinical practice guideline. General practitioners or general citizens are not supposed to use this guideline. The guideline committee has decided to include wide clinical issues such as etiological information, techniques of ERCP, the diagnosis, treatments, and monitoring of PEP in this guideline.
In this concise report, we described ten clinical questions, recommendations, and explanations pertaining to risk factors, diagnosis, prognostic factors, treatments, and preventive interventions in the medical practice for PEP.
We reported here the essence of the clinical practice guideline for PEP.
内镜逆行胰胆管造影术(ERCP)用于诊断和治疗胰腺和胆道疾病。内镜逆行胰胆管造影术后胰腺炎(PEP)是一种并发症,需要特别护理,也需要为此发病率制定临床实践指南。
列出并检查了 PEP 的诊断和治疗的关键临床问题,然后制定了临床问题。使用 PubMed(MEDLINE)和 Ichushi-web(日本医学文献)作为数据库。对于诊断测试准确性的研究,类似于 QUADAS-2 的项目,即从应用诊断测试的人群中随机选择、索引测试和参考测试的盲法、参考标准的完整性、测试实施的完整性、测试的相同时间和缺失数据进行了评估,以及研究对象、索引测试、参考标准和结果的间接性。推荐等级确定为强或弱。在临床实践中,主治医生的判断应该比临床实践指南中描述的建议更重要。胃肠病学家是本临床实践指南的目标用户。普通医生或普通公民不应该使用本指南。指南委员会决定在本指南中纳入广泛的临床问题,如病因信息、ERCP 技术、PEP 的诊断、治疗和监测。
在这份简明报告中,我们描述了十个与 PEP 的风险因素、诊断、预后因素、治疗和预防干预有关的临床问题、建议和解释。
我们在此报告了 PEP 临床实践指南的要点。